Vous êtes ici

Optima Medical Innovations Corp.

Liste d'échange: 
CSE
Statut: 
Delisted
Industrie: 
Life Sciences
Symbole: 
OMIC
Indice CSE: 
Devise: 

Optima Medical Innovations Corp. has three primary business segments: (1) Multidisciplinary specialty pain clinics with a focus on the treatment of chronic pain, including controlled applications of medical cannabis in Canada. Through an exclusive strategic alliance with Jack Nathan Medical Inc., the Company has access to one of the largest healthcare systems across Canada and Internationally for its education and research platform (currently over 1.5 million patient visits annually); (2) Development of formulated products for therapeutic purposes and natural health product alternatives at its manufacturing facility in Spokane.  The Company also has research agreements with multiple universities for medical cannabis research and development of new medical grade products; and (3) Distribution and sale of hemp-based cannabidiol (“CBD”) products in the United States, Canada, Europe, Brazil and China. The CBD product line contains EVR Premium Hemp Oil, which is an organically grown and non-GMO.

Vous êtes ici

Optima Medical Innovations Corp. (OMIC)

SEDAR Information

Information d'entreprise

Addresse
209-5460 Yonge Street
Toronto, ON M2N 6K7
Canada
Téléphone
416-250-1812
Fax
416-250-8245
Courriel
[email protected]
URL
https://tokicorp.com
Date d’inscription à la cote
Mercredi, juillet 4, 2018
Agent de transfert
Computershare Investor Services Inc.
Relations avec les investisseurs
Ashley Villarruel
Courriel
[email protected]
Vérificateur
Zeifmans LLP

Capitalisation

Capitalisation: 
47500131
Réservé à l'émission: 
5645679

Company Officers

Dr. Ommid John Faghani, Chairman, Chief Executive Officer
Scott Reeves, Director, Corporate Secretary
Dr. Ommid John Faghani, Interim Chief Financial Officer & President of TOK U.S. Operations
Kaivan Talachian, Director
Jacqueline Jordan, Director

Bulletins

05/01/2024

2024-0104 - Radiation - Optima Medical Innovations Corp. (OMIC)

le 5 janvier/January 2024

The common shares of Optima Medical Innovations Corp. will be delisted from the CSE at market close today, January 5, 2024.

Optimia Medical Innovations Corp. is currently suspended. See bulletin 2022-0504.

___________________________